BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8135775)

  • 1. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R.
    Costagliola S; Alcalde L; Tonacchera M; Ruf J; Vassart G; Ludgate M
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1027-34. PubMed ID: 8135775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.
    Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
    Mol Cell Endocrinol; 1995 Dec; 115(2):199-206. PubMed ID: 8824895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.
    Costagliola S; Many MC; Stalmans-Falys M; Tonacchera M; Vassart G; Ludgate M
    Endocrinology; 1994 Nov; 135(5):2150-9. PubMed ID: 7956939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice.
    Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
    Endocrinology; 1996 Nov; 137(11):4637-43. PubMed ID: 8895327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
    Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
    Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autoimmune hypothyroidism and subsequent hyperthyroidism by TSH receptor antibodies following subacute thyroiditis: a case report.
    Iitaka M; Kakinuma S; Yamanaka K; Fujimaki S; Oosuga I; Wada S; Katayama S
    Endocr J; 2001 Apr; 48(2):139-42. PubMed ID: 11456259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Painless Thyroiditis with Thyrotropin Receptor-blocking and Receptor-stimulating Autoantibodies.
    Kamijo K
    Intern Med; 2019 Nov; 58(21):3121-3123. PubMed ID: 31292406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
    Carayanniotis G; Huang GC; Nicholson LB; Scott T; Allain P; McGregor AM; Banga JP
    Clin Exp Immunol; 1995 Feb; 99(2):294-302. PubMed ID: 7851025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum.
    Morgenthaler NG; Minich WB; Willnich M; Bogusch T; Hollidt JM; Weglöhner W; Lenzner C; Bergmann A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):73-9. PubMed ID: 14654252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the extracellular domain of the thyrotrophin receptor in bacteria; production of thyrotrophin-binding inhibiting immunoglobulins.
    Costagliola S; Alcalde L; Ruf J; Vassart G; Ludgate M
    J Mol Endocrinol; 1994 Aug; 13(1):11-21. PubMed ID: 7999252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies.
    Diana T; Wüster C; Kanitz M; Kahaly GJ
    J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.
    Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G
    J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.